Related Experiment Videos
Effects of epidermal growth factor on growth control and signal transduction pathways in different human hepatoma
W C Hung1, L Y Chuang, J H Tsai
1Department of Biochemistry, Kaohsiung Medical College, Taiwan, R.O.C.
Abstract:
The roles of epidermal growth factor (EGF) on cell growth control and phosphatidylinositol signal transduction pathway in human hepatoma cell lines with different differentiated states were evaluated. Ligand binding study showed that only one receptor type with similar affinity was found in all three cell lines. Under serum-free conditions, EGF (10(-8)-10(-11) M) enhanced DNA synthesis and cell proliferation of the three cell lines in a dose-dependent manner. The response of the poorly differentiated HA22T/VGH hepatoma cells was most obvious whereas much smaller effects were found in Hep3B and Chang liver cells. The metabolism of phosphoinositides also increased in HA22T/VGH cells as compared with both Hep3B and Chang liver cells under basal and EGF-treated conditions. Our data indicated that EGF had different effects on different human hepatoma cell lines and its role might be more important in poorly differentiated hepatoma cells than in well differentiated ones.
Insights
Epidermal growth factor (EGF) stimulates cell growth and DNA synthesis in human hepatoma cells. Its effects are more pronounced in poorly differentiated cells, impacting phosphatidylinositol signaling.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Epidermal growth factor (EGF) plays a crucial role in regulating cell growth and survival.
- Hepatoma, a type of liver cancer, exhibits varying degrees of cellular differentiation, which can influence its response to growth factors.
- Understanding the signaling pathways involved in hepatoma cell proliferation is vital for developing targeted therapies.
Purpose of the Study:
- To investigate the role of epidermal growth factor (EGF) in cell growth control and phosphatidylinositol signal transduction.
- To compare the effects of EGF on human hepatoma cell lines with different differentiation states.
Main Methods:
- Ligand binding assays were used to determine EGF receptor affinity across cell lines.
- DNA synthesis and cell proliferation assays were conducted under serum-free conditions with varying EGF concentrations.
- Phosphoinositide metabolism was analyzed in basal and EGF-treated cells.
Main Results:
- A single EGF receptor type with similar binding affinity was observed in all tested hepatoma cell lines.
- EGF dose-dependently enhanced DNA synthesis and proliferation in all cell lines.
- Poorly differentiated HA22T/VGH cells showed the most significant response to EGF compared to Hep3B and Chang liver cells.
- Phosphoinositide metabolism was elevated in HA22T/VGH cells under both basal and EGF-stimulated conditions.
Conclusions:
- EGF exhibits differential effects on human hepatoma cell lines based on their differentiation status.
- The role of EGF in promoting cell proliferation and signaling appears to be more significant in poorly differentiated hepatoma cells.